Rosales, Rogelinda A.
HRN: 24-68-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/12/2024
03/18/2024
IV
4.5gms
Q8hrs
Sepsis Sec To CAP-MR; T/c Pulmo Mass
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes